PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))

Term ID

CHEBI:88841

Synonyms

(2-{[(2R)-3-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-2-[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Docosapentaenoyl-2-myristoleoyl-sn-glycero-3-phosphocholine
1-Osbondoyl-2-myristoleoyl-sn-glycero-3-phosphocholine
GPCho(22:5/14:1)
GPCho(22:5n6/14:1n5)
GPCho(22:5w6/14:1w5)
GPCho(36:6)
Lecithin
PC aa C36:6
PC(22:5/14:1)
PC(22:5n6/14:1n5)
PC(22:5w6/14:1w5)
PC(36:6)
Phosphatidylcholine(22:5/14:1)
Phosphatidylcholine(22:5n6/14:1n5)
Phosphatidylcholine(22:5w6/14:1w5)
Phosphatidylcholine(36:6)

(all 17)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))

Phenotype where environments contain PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))

Phenotype modified by environments containing PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))

Phenotype affecting PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))

Human Disease Model